Phase 2Completed
To Compare the Effect of Inhaled Insulin With Subcutaneously Injected Insulin in Subjects With Type 2 Diabetes Mellitus.
- Sponsor
- Mannkind Corporation (Industry)
- Enrolment
- 16 planned
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Technosphere/Insulin
- Ages
- adults, older adults
- Registry
- NCT00419302
Full record on ClinicalTrials.gov
From the registry
This trial was designed to compare meal related inhalation of Technosphere/Insulin to subcutaneous regular insulin in patients with type 2 diabetes.
Primary outcomes
- Glycemic response to a meal challenge
History
Last registry update
Registered
Study completion
Started